Marc Beer Role to the Health Industry

Marc Beer is a prominent businessman excelling in biotechnology, commercialization, and pharmaceuticals. He has over 25vyaers of experience in these fields making significant contributions and providing solutions to many health problems. Marc Beer is devoted to learn and share his experiences to create a better health industry where people needs are met. As a graduate from Miami University Marc Beer has extensive skills and expertise to run the health business. He has worked in several companies serving at the top positions to ensure that he makes significant changes and provides various diagnostics for different diseases.

 

Previously Marc Beer served at the Good Start Genetics as the founder and the Chair of the board of directors later at the Abbot Laboratories where he made significant contributions. Marc Beer has also worked at Genzyme as the Vice President and ensured that the company was traded publicly and later joined Viacell Company where he played a significant role in changing the structure of the organization in the company. Viacell dealt with the collection, Preservation, and improvement of Umbilical cord blood stem cells and Marc Beer provided his service for about seven years.

 

Later Marc Beer joined forces with Ramon Iglesias to launch Renovia Company based in the Boston United States and dealing with a variety of services including providing solutions for women suffering from urinary incontinence. Marc Beer raised money used in constructing a health center based in Boston that has several experts devoted to research and provide solutions to treat urinary incontinence including pelvic disorder. Marc Beer works closely with the Renovia management team to ensure there is smooth running and all patients are treated with respect and dignity in each level. He has made a significant contribution to the health industry including the creation of Leva Digital product fitted with all the necessary kits to help improve the strength of pelvic muscles. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html

 

Recently Marc Beer received an appointment from LumeNXT to serve as the head of the board of directors. LumeNXT is a private company focused on Surgical Illumination. They appointed Marc Beer for his extensive skills and experience in the health industry. As the char of the board, Marc Beer will be able to share his ideas with the other surgeons and engineers. LumeNXT has adopted the use of proprietary technology to ensure that all their patients are provided with high quality services.

 

The co-founder of LumeNXT Paul Rhyne shared that with Marc Beer on the team of surgeons providing his extensive skills and experience the company will be able to conduct many successful surgeries as well as increase the logistics of the company. LumeNXT uses modern advanced technology to perform operations; some of the techniques used include heat reduction mechanism to aid in the surgery effectiveness process.

“CEO Marc Bell Leads Renovia in Raising $42 Million in Funding “

Renovia Inc. (“Renovia”) is a startup firm focused on new innovations regarding women’s health. Renovia was co-founded by Marc Beer. Through his leadership as Chief Executive Officer (CEO) of the firm, they have secured a Series B round of funding to the tune of $32 million together with $10 million in venture debt. The funding will be used to expand the efforts of Renovia to develop products to treat and improve the health of millions of women affected by pelvic floor disorders such as urinary incontinence. The first such product developed by Renovia, Leva, was approved by the Food and Drug Administration (FDA) in April of 2018.

 

This round of funding was backed by three leading investors in the healthcare sector: Perceptive Advisors, Ascension Ventures and the Longwood Fund. Doubtless, the confidence in Renovia’s research and development efforts expressed by these investors is due to the stellar reputation of Renovia’s co-founder and CEO, Marc Beer. Mr. Beer previously worked as a strategic consultant at the publically traded biotechnology firm OvaScience (Nasdaq: OVAS). In August 2018, OvaScience indicated that they would be merging with Millendo Therapeutics.

 

Marc Beer boasts an executive career that has spanned over 25 years. This includes development and market launch expertise in diagnostic, device, biotech and pharmaceutical enterprises. Mr. Beer was the founding CEO of  ViaCell back in April of 2000. This biotech firm developed unique products focused on umbilical cord blood stem cells. Under Beer’s leadership, ViaCell grew into a company of over 300 employees. They went public in 2005 and were subsequently acquired by PerkinElmer (NYSE: PKI) in 2007. During his tenure at ViaCell, Mr. Beer was also a member of the Board of Directors at Erytech Pharma (Nasdaq: EPYP). Learn more: https://www.crunchbase.com/person/marc-beer

 

Before taking on his role as CEO of ViaCell, Bell held a number of executive positions at Genzyme. As Vice President of Global Marketing, he oversaw the global launch of a number of products that targeted rare disease populations worldwide. Preceding his role at Genzyme, Marc served in a number of marketing and sales positions in the diagnostic and pharmaceutical divisions of Abbott Laboratories. Furthermore, Marc previously served on the Biotechnology Industry Organization Emerging Companies Section Governing Board